Portal de Periódicos da CAPES

The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitis

2017; Elsevier BV; Volume: 27; Issue: 9 Linguagem: Inglês

10.1016/j.bmcl.2017.02.078

1464-3405

John Liddle, Benjamin Beaufils, Margaret Binnie, Anne Bouillot, Alexis Denis, Michael M. Hann, Carl Haslam, Duncan S. Holmes, Jon P. Hutchinson, Michael Kranz, Andrew McBride, Olivier Mirguet, Damian J. Mole, Christopher G. Mowat, Sandeep Pal, Paul Rowland, Lionel Trottet, Iain Uings, Ann L. Walker, Scott P. Webster,

Bipolar Disorder and Treatment

A series of potent, competitive and highly selective kynurenine monooxygenase inhibitors have been discovered via a substrate-based approach for the treatment of acute pancreatitis. The lead compound demonstrated good cellular potency and clear pharmacodynamic activity in vivo.